Posted On: 12/07/2013 2:32:21 PM
Post# of 63752
From Pharma PRs
- Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
1:30 pm - PR Newswire Saturday 7th
SYN Chart
(0)
(0)Scroll down for more posts ▼
